FR2710534B1 - Solvant de stabilisation, composition pharmaceutique le contenant, et son procédé de préparation. - Google Patents

Solvant de stabilisation, composition pharmaceutique le contenant, et son procédé de préparation.

Info

Publication number
FR2710534B1
FR2710534B1 FR9411590A FR9411590A FR2710534B1 FR 2710534 B1 FR2710534 B1 FR 2710534B1 FR 9411590 A FR9411590 A FR 9411590A FR 9411590 A FR9411590 A FR 9411590A FR 2710534 B1 FR2710534 B1 FR 2710534B1
Authority
FR
France
Prior art keywords
preparation
pharmaceutical composition
composition containing
stabilization solvent
stabilization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9411590A
Other languages
English (en)
Other versions
FR2710534A1 (fr
Inventor
Shreerham Narahari Agharkar
Uday S Cogate
Thomas Cavanak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Priority to FR9411590A priority Critical patent/FR2710534B1/fr
Publication of FR2710534A1 publication Critical patent/FR2710534A1/fr
Application granted granted Critical
Publication of FR2710534B1 publication Critical patent/FR2710534B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9411590A 1994-09-28 1994-09-28 Solvant de stabilisation, composition pharmaceutique le contenant, et son procédé de préparation. Expired - Fee Related FR2710534B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9411590A FR2710534B1 (fr) 1994-09-28 1994-09-28 Solvant de stabilisation, composition pharmaceutique le contenant, et son procédé de préparation.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9411590A FR2710534B1 (fr) 1994-09-28 1994-09-28 Solvant de stabilisation, composition pharmaceutique le contenant, et son procédé de préparation.

Publications (2)

Publication Number Publication Date
FR2710534A1 FR2710534A1 (fr) 1995-04-07
FR2710534B1 true FR2710534B1 (fr) 1996-07-05

Family

ID=9467371

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9411590A Expired - Fee Related FR2710534B1 (fr) 1994-09-28 1994-09-28 Solvant de stabilisation, composition pharmaceutique le contenant, et son procédé de préparation.

Country Status (1)

Country Link
FR (1) FR2710534B1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991004734A1 (fr) * 1989-09-29 1991-04-18 Cetus Corporation Compositions pharmaceutiques contenant de l'acide 4,6-tioxoheptanoïque ou ses derives
DE69320206T2 (de) * 1992-11-27 1999-02-11 Napro Biotherapeutics Inc Paclitaxel enthaltende injizierbare zusammensetzung
AU5553894A (en) * 1992-11-27 1994-06-22 F.H. Faulding & Co. Limited Injectable taxol composition

Also Published As

Publication number Publication date
FR2710534A1 (fr) 1995-04-07

Similar Documents

Publication Publication Date Title
MA26466A1 (fr) Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation .
OA07282A (fr) Composition pharmaceutique lyophilisée contenant de l'interféron procédé pour la préparation et procédé pour sa stabilisation.
DZ2045A1 (fr) Amides thérapeutiques, procédé pour leur préparation et compositions les contenant.
FR2694290B1 (fr) Nouvelles phénylimidazolidines éventuellement substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
DZ2197A1 (fr) Dérivés de 6-phénylpyridyl-2-amine, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2300A1 (fr) Dérivés 6,5-hétérobicycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2299A1 (fr) Dérivés 6,6-hétérobicycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2634A1 (fr) Dérivés de pleuromutiline nouveaux procédé pour leur préparation et compositions pharmaceutiques lescontenant.
FR2786771B1 (fr) Procede de stabilisation d'un macrolide poly-ene et composition pharmaceutique contenant un tel compose
FR2671086B1 (fr) Peptides opiouides, leur procede de preparation, et composition pharmaceutique contenant ces peptides.
DZ2155A1 (fr) Aazétidines, procédé pour leur préparation, et co mpositions pharmaceutiques les contenant.
ATE104666T1 (de) Abkoemmlinge von benzocycloalkenyldihydroxyalkansaeuren, verfahren zu deren herstellung und diese enthaltende pharmazeutika.
DZ2680A1 (fr) Dérivé de thiazolidinedione nouveau procédé pour sa préparation et composition pharmaceutique le contenant.
FR2705095B1 (fr) Nouveaux indoles substitués, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
ZA934037B (en) Novel biologically active eburnamenine derivatives, pharmaceutical compositions containing them and process for preparing same.
ATE48137T1 (de) Neue benzodipyrrole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
DE3887068D1 (de) 2,2-Dimethylchromenderivate, Verfahren zur Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.
FR2720397B1 (fr) Nouveaux oxathiolanes, leur procédé de préparation et les compositions pharmaceutiques qui en renferment.
FR2717802B1 (fr) Nouveaux composés aromatiques, procédé pour leur préparation et compositions pharmaceutiques en contenant.
LTIP911A (en) Indenoindole compounds i,process for preparing thereof,pharmaceutical compositions containing this compounds,and their use
DZ1977A1 (fr) Procédé de préparation du trihydrate du (2r,3s)-3-benzoylamino-2-hydroxy-3-phenylpro-pionate de 4,10-diacetoxy-2alpha-benzoyloxy-5beta, 20-epoxy-1,7beta-dihydroxy-9-oxo-tax-11-en-13alpha-yle.
FR2710534B1 (fr) Solvant de stabilisation, composition pharmaceutique le contenant, et son procédé de préparation.
FR2704857B1 (fr) Nouvelles benzodioxines substituées, leur procédé de préparation et les compositions pharmaceutiques les contenant.
HUT49876A (en) Process for producing 6-oxopyridazine derivatives and pharmaceutical compositions comprising same
DZ2250A1 (fr) Composés nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20100531